Why we should have more collaboration on HTA in Europe: the example of sofosbuvir
نویسندگان
چکیده
Results The results of the questionnaire showed that, 7 months after sofosbuvir received market authorisation, in 11 countries the assessment of the effectiveness sofosbuvir had not yet started, in nine it was ongoing and in seven it was completed. Of the 11 countries that had not started an assessment, five Eastern European countries reported that the MAH had not yet submitted an application for reimbursement of sofosbuvir. The analysis also showed that in the seven reports from different European HTA organisations several relative effectiveness assessment elements were in common.
منابع مشابه
Collaboration Between Researchers and Knowledge Users in Health Technology Assessment: A Qualitative Exploratory Study
Background Collaboration between researchers and knowledge users is increasingly promoted because it could enhance more evidence-based decision-making and practice. These complex relationships differ in form, in the particular goals they are trying to achieve, and in whom they bring together. Although much is understood about why partnerships form, relatively little is known about how collabora...
متن کاملHTA – Algorithm or Process?; Comment on “Expanded HTA: Enhancing Fairness and Legitimacy”
Daniels, Porteny and Urrutia et al make a good case for the idea that that public decisions ought to be made not only “in the light of” evidence but also “on the basis of” budget impact, financial protection and equity. Health technology assessment (HTA) should, they say, be accordingly expanded to consider matters additional to safety and cost-effectiveness. They also complain that most HTA re...
متن کاملVariation in Health Technology Assessment and Reimbursement Processes in Europe.
BACKGROUND It has been suggested that differences in health technology assessment (HTA) processes among countries, particularly within Europe, have led to inequity in patient access to new medicines. OBJECTIVES To provide an up-to-date snapshot analysis of the present status of HTA and reimbursement systems in select European countries, and to investigate the implications of these processes, ...
متن کاملDemography and the Coronavirus Pandemic
Abstract. One of the most urgent policy issues related to the COVID-19 pandemic in Europe concerns the extent and ways in which demographics have determined different patterns of mortality between groups and regions, and whether and how the pandemic and its economic consequences will affect population dynamics in the future. Post-pandemic policy evaluations on the spread of COVID-19 and the im...
متن کاملAnalysis of Duplication and Timing of Health Technology Assessments on Medical Devices in Europe.
OBJECTIVES Strengthening efforts toward better collaboration plays a pivotal role in the assessment of medical devices to reduce overlap and save resources. This study explored the level of duplication in health technology assessments (HTA) of medical devices in Europe and their respective timing in order to identify areas for better collaboration. METHODS An analysis of European HTA reports ...
متن کامل